Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
合伙人律师
Boyle, Chris
合伙人律师

Capabilities

Suggested News & Insights

Animal Health, Nutrition & Technology Innovation – Shaping the Future of Animal HealthMonday, March 2, 2026 - Tuesday, March 3, 2026
活动
Sidley Represents Precision NeuroMed in Its Strategic Partnership With Brainlab SEFebruary 27, 2026
公告
Veterinary Biologics and Biosimilars: Routes to Approval and Commercialization in the U.S., EU, and UKFebruary 20, 2026
Animal Health Update
Drug Pricing and Medicaid Rebate Reporting: Enforcement Risk RemainsFebruary 17, 2026
Reuters
Sidley Represents Vivo Capital on Its Acquisition of Dutscher GroupFebruary 4, 2026
公告
Sidley Represents RoundTable Healthcare Partners in Its Partnership and Investment in ColorescienceFebruary 2, 2026
公告